CDXS - Codexis, Inc.
About Codexis, Inc. (https://www.codexis.com)
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Alison Moore | President, Chief Executive Officer & Director | 1967 | $1,002,062 USD |
| Georgia L. Erbez | Chief Financial Officer & Chief Business Officer | 1967 | $745,963 USD |
| Stefan Lutz | Chief Scientific Officer | – | $729,162 USD |
| Senator Byron L. Dorgan | Consultant | 1943 | $26,786 USD |
| Britton Jimenez | Senior Vice President of Sales & Marketing | – | – |
| Carrie McKim | Director of Investor Relations | – | – |
| John Schiffhauer | Senior Vice President of Intellectual Property | – | – |
| Karen Frechou-Armijo | Senior Vice President & Head of Human Resources | – | – |